Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE1842.00-22 (-1.18 %)
PREV CLOSE () 1864.00
OPEN PRICE () 1844.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 95615
TODAY'S LOW / HIGH ()1833.90 1854.30
52 WK LOW / HIGH ()1547.25 2047.55
NSE1840.00-21 (-1.13 %)
PREV CLOSE() 1861.00
OPEN PRICE () 1845.00
BID PRICE (QTY) 1840.00 (183)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1445071
TODAY'S LOW / HIGH() 1834.00 1854.50
52 WK LOW / HIGH ()1548 2046.9
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1993

Management Info :

Dilip Shantilal Shanghvi - Chairman Kirti Ganorkar - Managing Director

Registered Office :

Address : Sun Pharma Advanced Research Centre (S P A R C),Tandalja, ,
Vadodara,
Gujarat-390012

Phone : 0265- 5515500 / 5515600 / 5515700

Website : www.sunpharma.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
09Sep Sun Pharmaceutical incorporates subsid
Sun Pharmaceutical Industries has incorporated an indirect wholly owned..
09Sep Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed that ‘Sun Pharma Global Treas..
01Sep Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed that it enclosed a copy of th..
17Aug Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed that the company and certain..
31Jul Sun Pharma reports 27% rise in Q1 cons
Sun Pharmaceutical Industries has reported its results for the first qua..
Financials
in Millions
QTR Jun 26 ANNUAL 26
Net Profit11151.426234.2
Gross Profit 14864.5 37941.2
Operating Profit 21043.866000.2
Net Sales 57411.3207546.4
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 25586.10 (1.24%)
M.Cap ( in Cr)
54368.68
Kwality Pharma (BSE)
 3642.50 (3.65%)
M.Cap ( in Cr)
3779.53
Concord Biotech (BSE)
 1506.65 (3.72%)
M.Cap ( in Cr)
15762.00
Rubicon Research (BSE)
 1838.35 (2.67%)
M.Cap ( in Cr)
30430.56
Onesource Specialty (BSE)
 1592.40 (3.04%)
M.Cap ( in Cr)
18260.51
Shareholding Pattern
PROMOTERS 54.48%
MUTUAL FUNDS/UTI 12.84%
NON-INSTITUTION 8.82%
FI/BANKS/INSURANCE 7.07%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX74781.76-120.83 (-0.16%)
NIFTY23398.10-79.70 (-0.34%)
Dow Jones 52573.29509.19 (0.98%)
Nasdaq 26333.04251.31 (0.96%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI